Pharmaceutical Supply Chain

Book description

Error-proofing in the production process of pharmaceuticals isn‘t just a matter of good business, it has life-and-death implications for consumers. To that end, the 2013 Drug Quality and Security Act in large part requires new mandates on tracking and tracing chain of custody in the supply chain. Pharmaceutical Supply Chain: Drug Quality and Securi

Table of contents

  1. Front Cover (1/2)
  2. Front Cover (2/2)
  3. Contents (1/2)
  4. Contents (2/2)
  5. Preface
  6. Acknowledgments
  7. Author
  8. Introduction: The Good, the Bad, the Ugly, and the Necessary (1/3)
  9. Introduction: The Good, the Bad, the Ugly, and the Necessary (2/3)
  10. Introduction: The Good, the Bad, the Ugly, and the Necessary (3/3)
  11. Chapter 1: H.R. 3204: The Journey and Expected Destination (1/4)
  12. Chapter 1: H.R. 3204: The Journey and Expected Destination (2/4)
  13. Chapter 1: H.R. 3204: The Journey and Expected Destination (3/4)
  14. Chapter 1: H.R. 3204: The Journey and Expected Destination (4/4)
  15. Chapter 2: The World of Human Drug Compounding: Hope and Change (1/4)
  16. Chapter 2: The World of Human Drug Compounding: Hope and Change (2/4)
  17. Chapter 2: The World of Human Drug Compounding: Hope and Change (3/4)
  18. Chapter 2: The World of Human Drug Compounding: Hope and Change (4/4)
  19. Chapter 3: Pharmacy Compounding: The Supply Chain World (1/4)
  20. Chapter 3: Pharmacy Compounding: The Supply Chain World (2/4)
  21. Chapter 3: Pharmacy Compounding: The Supply Chain World (3/4)
  22. Chapter 3: Pharmacy Compounding: The Supply Chain World (4/4)
  23. Chapter 4: Track and Trace: Not Hide and Seek (1/4)
  24. Chapter 4: Track and Trace: Not Hide and Seek (2/4)
  25. Chapter 4: Track and Trace: Not Hide and Seek (3/4)
  26. Chapter 4: Track and Trace: Not Hide and Seek (4/4)
  27. Chapter 5: Land of the Giants—and Land of the Totes (1/4)
  28. Chapter 5: Land of the Giants—and Land of the Totes (2/4)
  29. Chapter 5: Land of the Giants—and Land of the Totes (3/4)
  30. Chapter 5: Land of the Giants—and Land of the Totes (4/4)
  31. Chapter 6: The Customer/Patient Touchpoint—Literally and Electronically: Internet Pharmacies, Pill Mills, and Other Lurking Dangers (1/4)
  32. Chapter 6: The Customer/Patient Touchpoint—Literally and Electronically: Internet Pharmacies, Pill Mills, and Other Lurking Dangers (2/4)
  33. Chapter 6: The Customer/Patient Touchpoint—Literally and Electronically: Internet Pharmacies, Pill Mills, and Other Lurking Dangers (3/4)
  34. Chapter 6: The Customer/Patient Touchpoint—Literally and Electronically: Internet Pharmacies, Pill Mills, and Other Lurking Dangers (4/4)
  35. Chapter 7: When Things Go Bump in the Night: Reverse Logistics (1/4)
  36. Chapter 7: When Things Go Bump in the Night: Reverse Logistics (2/4)
  37. Chapter 7: When Things Go Bump in the Night: Reverse Logistics (3/4)
  38. Chapter 7: When Things Go Bump in the Night: Reverse Logistics (4/4)
  39. Chapter 8: All Those “Lettered” Government Agencies (1/4)
  40. Chapter 8: All Those “Lettered” Government Agencies (2/4)
  41. Chapter 8: All Those “Lettered” Government Agencies (3/4)
  42. Chapter 8: All Those “Lettered” Government Agencies (4/4)
  43. Chapter 9: Pulling It All Together: Public Policy and Other Items of Note (1/4)
  44. Chapter 9: Pulling It All Together: Public Policy and Other Items of Note (2/4)
  45. Chapter 9: Pulling It All Together: Public Policy and Other Items of Note (3/4)
  46. Chapter 9: Pulling It All Together: Public Policy and Other Items of Note (4/4)
  47. Chapter 10: Drug Quality and Security Hall of Fame (1/4)
  48. Chapter 10: Drug Quality and Security Hall of Fame (2/4)
  49. Chapter 10: Drug Quality and Security Hall of Fame (3/4)
  50. Chapter 10: Drug Quality and Security Hall of Fame (4/4)
  51. Back Cover

Product information

  • Title: Pharmaceutical Supply Chain
  • Author(s): Fred A. Kuglin
  • Release date: July 2015
  • Publisher(s): CRC Press
  • ISBN: 9781482258943